Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.40

LSTA FY 2005 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2005 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35,262

Gross Profit

$10,48629.7% margin

Operating Income

-$2M-4540.0% margin

Net Income

-$2M-4948.8% margin

EPS (Diluted)

$-3712.85

Cash Flow

Operating Cash Flow

-$833,996

Free Cash Flow

-$833,996

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$642,681

Total Liabilities

$2M

Stockholders' Equity

-$2M

Cash & Equivalents

$488,872

← FY 2006 All Quarters